Breaking News
Sort by:
Top Post
Ai-powered Drug Discovery Company Healx Opens New Labs at Chesterford Research Park
Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery for rare […]
Athos Therapeutics Announces Research Collaboration to Advance Precision Medicine in Inflammatory Bowel Disease
Athos Therapeutics, Inc. (“Athos”), a late-stage preclinical biotech company using artificial intelligence to develop small […]
ABL Partners With KaliVir Immunotherapeutics to Advance Development of Oncolytic Viruses
ABL, a pure play Contract Development and Manufacturing Organization (CDMO) specialized in the development and […]
Hansa Biopharma Announces First Patient Treated in the Post-authorization Efficacy Study (PAES) of Idefirix® (Imlifidase) in Highly Sensitized Kidney Transplant Patients
Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), pioneer in enzyme technology for rare immunological conditions, […]
Diabetes Patients Set to Benefit From Heart Disease Data Investment
People living with diabetes could be set to benefit from a major research initiative to […]
Researchers Create a Single-cell Framework to Potentially Enhance CAR T-cell Therapy
St. Jude Children’s Research Hospital scientists have demonstrated that the long-term performance of cancer-killing chimeric […]
Skyhawk Announces Collaboration Agreement with Sanofi for Oncology and Immunology Targets
Skyhawk Therapeutics, Inc. today announced the signing of an exclusive worldwide collaboration agreement with Sanofi […]
Enosi Therapeutics Partners with Danuo Science Group to Accelerate Multiple Therapeutic Programs
Enosi Therapeutics, a Delaware Corporation, focused on providing industry-leading therapeutics for cancer and autoimmune diseases, […]
The PanDIA-1 Study, for Early Detection of Pancreatic Cancer in Newly Onset Type 2 Diabetics, Moves Into Next Phase
Immunovia today announced the PanDIA-1 study for the early detection of pancreatic cancer in newly […]
Cepheid and BioGX Announce Collaboration to Develop Monkeypox PCR Test for the GeneXpert® System
Cepheid and BioGX today announced a collaboration between the two companies to deliver a PCR […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more